Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus.

Vardas E, Kaleebu P, Bekker LG, Hoosen A, Chomba E, Johnson PR, Anklesaria P, Birungi J, Barin B, Boaz M, Cox J, Lehrman J, Stevens G, Gilmour J, Tarragona T, Hayes P, Lowenbein S, Kizito E, Fast P, Heald AE, Schmidt C.

AIDS Res Hum Retroviruses. 2010 Aug;26(8):933-42. doi: 10.1089/aid.2009.0242.

PMID:
20666584
2.

Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examination.

Heald AE, Fudman EJ, Anklesaria P, Mease PJ; 13G01 Study Team.

J Rheumatol. 2010 May;37(5):1042-8. doi: 10.3899/jrheum.090827. Epub 2010 Mar 15.

PMID:
20231202
3.

Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.

Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM, Anklesaria P, Heald AE.

J Rheumatol. 2010 Apr;37(4):692-703. doi: 10.3899/jrheum.090817. Epub 2009 Dec 23.

PMID:
20032102
4.

Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Carter BJ, Anklesaria P, Choi S, Engelhardt JF.

Antioxid Redox Signal. 2009 Jul;11(7):1569-86. doi: 10.1089/ARS.2008.2414. Review.

5.

Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.

Mease PJ, Hobbs K, Chalmers A, El-Gabalawy H, Bookman A, Keystone E, Furst DE, Anklesaria P, Heald AE.

Ann Rheum Dis. 2009 Aug;68(8):1247-54. doi: 10.1136/ard.2008.089375. Epub 2008 Aug 4.

PMID:
18678578
6.

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

Mehendale S, van Lunzen J, Clumeck N, Rockstroh J, Vets E, Johnson PR, Anklesaria P, Barin B, Boaz M, Kochhar S, Lehrman J, Schmidt C, Peeters M, Schwarze-Zander C, Kabamba K, Glaunsinger T, Sahay S, Thakar M, Paranjape R, Gilmour J, Excler JL, Fast P, Heald AE.

AIDS Res Hum Retroviruses. 2008 Jun;24(6):873-80. doi: 10.1089/aid.2007.0292.

PMID:
18544020
7.

Calculating expected lung deposition of aerosolized administration of AAV vector in human clinical studies.

Leung K, Louca E, Munson K, Dutzar B, Anklesaria P, Coates AL.

J Gene Med. 2007 Jan;9(1):10-21.

PMID:
17154340
8.

Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.

Tatalick LM, Gerard CJ, Takeya R, Price DN, Thorne BA, Wyatt LM, Anklesaria P.

Vaccine. 2005 Apr 8;23(20):2628-38.

PMID:
15780446
9.

In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma.

Bruckheimer E, Harvie P, Orthel J, Dutzar B, Furstoss K, Mebel E, Anklesaria P, Paul R.

Cancer Gene Ther. 2004 Feb;11(2):128-34.

PMID:
14671672
10.

Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs.

Harvie P, Dutzar B, Galbraith T, Cudmore S, O'Mahony D, Anklesaria P, Paul R.

J Liposome Res. 2003 Nov;13(3-4):231-47.

PMID:
14670229
11.

Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene.

Ueno NT, Bartholomeusz C, Xia W, Anklesaria P, Bruckheimer EM, Mebel E, Paul R, Li S, Yo GH, Huang L, Hung MC.

Cancer Res. 2002 Nov 15;62(22):6712-6.

12.

A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma.

Villaret D, Glisson B, Kenady D, Hanna E, Carey M, Gleich L, Yoo GH, Futran N, Hung MC, Anklesaria P, Heald AE.

Head Neck. 2002 Jul;24(7):661-9.

PMID:
12112540
13.

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.

Hortobagyi GN, Ueno NT, Xia W, Zhang S, Wolf JK, Putnam JB, Weiden PL, Willey JS, Carey M, Branham DL, Payne JY, Tucker SD, Bartholomeusz C, Kilbourn RG, De Jager RL, Sneige N, Katz RL, Anklesaria P, Ibrahim NK, Murray JL, Theriault RL, Valero V, Gershenson DM, Bevers MW, Huang L, Lopez-Berestein G, Hung MC.

J Clin Oncol. 2001 Jul 15;19(14):3422-33.

PMID:
11454891
14.

Gene therapy: a molecular approach to cancer treatment.

Anklesaria P.

Curr Opin Mol Ther. 2000 Aug;2(4):426-32. Review.

PMID:
11249773
15.

E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.

Ueno NT, Bartholomeusz C, Herrmann JL, Estrov Z, Shao R, Andreeff M, Price J, Paul RW, Anklesaria P, Yu D, Hung MC.

Clin Cancer Res. 2000 Jan;6(1):250-9.

16.

GaLV pseudotyped vectors and cationic lipids transduce human CD34+ cells.

Dybing J, Lynch CM, Hara P, Jurus L, Kiem HP, Anklesaria P.

Hum Gene Ther. 1997 Sep 20;8(14):1685-94.

PMID:
9322871
17.

Weight, skinfolds and circumference characteristics of poor elderly people in Mumbai, India.

Manandhar MC, Anklesaria PS, Ismail SJ.

Asia Pac J Clin Nutr. 1997 Sep;6(3):191-9.

18.

Gastric bacterial overgrowth accompanies profound acid suppression.

Patel TA, Abraham P, Ashar VJ, Bhatia SJ, Anklesaria PS.

Indian J Gastroenterol. 1995 Oct;14(4):134-6.

PMID:
8868355
19.

Portal venous pressure and the serum-ascites albumin concentration gradient.

Harjai KJ, Kamble MS, Ashar VJ, Anklesaria PS, Ratnam KL, Abraham P.

Cleve Clin J Med. 1995 Jan-Feb;62(1):62-7.

PMID:
7859404
20.

A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells.

Woodman RC, Newburger PE, Anklesaria P, Erickson RW, Rae J, Cohen MS, Curnutte JT.

Blood. 1995 Jan 1;85(1):231-41.

21.

Stromal cell-mediated stimulation of osteoclastogenesis.

Shevde N, Anklesaria P, Greenberger JS, Bleiberg I, Glowacki J.

Proc Soc Exp Biol Med. 1994 Apr;205(4):306-15.

PMID:
8171053
22.

Diverse signaling pathways rendezvous at mitogen-activated protein kinase.

Anklesaria P.

Exp Hematol. 1993 Oct;21(11):1403-4. No abstract available.

PMID:
8405219
23.

Effects of macrophage colony stimulating factor and granulocyte-macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells.

Liggett W Jr, Shevde N, Anklesaria P, Sohoni S, Greenberger J, Glowacki J.

Stem Cells. 1993 Sep;11(5):398-411.

PMID:
8241951
24.

Expression of p210 bcr/abl increases hematopoietic progenitor cell radiosensitivity.

Santucci MA, Anklesaria P, Laneuville P, Das IJ, Sakakeeny MA, FitzGerald TJ, Greenberger JS.

Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):831-6.

PMID:
8344852
25.

Involvement of prostaglandins in chilli-induced early gastric vascular damage in adult Wistar rat.

Thatte UM, Pai NR, Varade MA, Anklesaria PS, Dahanukar SA.

Indian J Gastroenterol. 1993 Jul;12(3):92-4.

PMID:
8354537
26.
27.

Origin of stromal cells associated with osteoclast recruitment in s.c. implants of bone particles in chimeric mice.

Bleiberg I, Glowacki J, Anklesaria P, Greenberger JS.

Exp Hematol. 1992 Sep;20(8):957-61.

PMID:
1505641
28.

Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma.

Teixidó J, Hemler ME, Greenberger JS, Anklesaria P.

J Clin Invest. 1992 Aug;90(2):358-67.

29.
30.

The v-src oncogene may not be responsible for the increased radioresistance of hematopoietic progenitor cells expressing v-src.

Santucci MA, Anklesaria P, Anderson SM, Das IJ, FitzGerald TJ, Valinsky H, Kase KR, Sakakeeny MA, Greenberger JS.

Radiat Res. 1992 Mar;129(3):297-303.

PMID:
1311863
31.
32.

Humoral and cell surface interactions during gamma-irradiation leukemogenesis in vitro.

Greenberger J, Leif J, Crawford D, Anklesaria P, English D, Sakakeeny M, Rubin J, Pierce J, Shadduck R, FitzGerald TJ.

Exp Hematol. 1992 Jan;20(1):92-102.

PMID:
1533594
33.

Hemonectin mediates adhesion of engrafted murine progenitors to a clonal bone marrow stromal cell line from Sl/Sld mice.

Anklesaria P, Greenberger JS, Fitzgerald TJ, Sullenbarger B, Wicha M, Campbell A.

Blood. 1991 Apr 15;77(8):1691-8.

34.

Polymorphonuclear and monocyte functions in measles.

Thatte UM, Gangal PS, Kulkarni MR, Anklesaria PS, Kumta NB, Dahanukar SA.

J Trop Pediatr. 1991 Mar;37(2):67-70. doi: 10.1093/tropej/37.2.67.

PMID:
2027167
35.

Biochemical and functional characterization of proteoglycans produced by Sl/Sld murine bone marrow stromal cell lines.

Bentley SA, Kirby SL, Anklesaria P, Greenberger JS.

J Cell Physiol. 1990 Oct;145(1):53-9.

PMID:
2211843
36.

Hematopoietic stem cell- and marrow stromal cell-specific requirements for gamma irradiation leukemogenesis in vitro.

Greenberger JS, Wright E, Henault S, Anklesaria P, Leif J, Sakakeeny MA, FitzGerald TJ, Pierce JH, Kase K.

Exp Hematol. 1990 Jun;18(5):408-15.

PMID:
2186923
37.

Gamma-irradiation response of cocultivated bone marrow stromal cell lines of differing intrinsic radiosensitivity.

Santucci MA, FitzGerald TJ, Harigaya K, Woda B, Sakakeeny MA, Anklesaria P, Kase K, Holland CA, Greenberger JS.

Int J Radiat Oncol Biol Phys. 1990 May;18(5):1083-92.

PMID:
2347717
38.

Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation.

Anklesaria P, Teixidó J, Laiho M, Pierce JH, Greenberger JS, Massagué J.

Proc Natl Acad Sci U S A. 1990 May;87(9):3289-93.

39.

Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate.

FitzGerald TJ, Henault S, Sakakeeny M, Santucci MA, Pierce JH, Anklesaria P, Kase K, Das I, Greenberger JS.

Radiat Res. 1990 Apr;122(1):44-52.

PMID:
2320725
40.

Improved hematopoiesis in anemic Sl/Sld mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment.

Anklesaria P, FitzGerald TJ, Kase K, Ohara A, Greenberger JS.

Blood. 1989 Aug 15;74(3):1144-51.

41.

Recombinant murine GM-CSF increases resistance of some factor dependent hematopoietic progenitor cells to low-dose-rate gamma irradiation.

FitzGerald TJ, Henault S, Santucci MA, Anklesaria P, Zak S, Kase K, Farber N, Pierce JH, Ohara A, Greenberger JS.

Int J Radiat Oncol Biol Phys. 1989 Aug;17(2):323-35.

PMID:
2666365
42.

Retroviral src gene expression in continuous marrow culture increases the self-renewal capacity of multilineage hematopoietic stem cells.

Ohta M, Anklesaria P, Wheaton M, Ohara A, Pierce JH, Holland CA, Greenberger JS.

Leukemia. 1989 Mar;3(3):206-26.

PMID:
2918758
43.

Long-term bone marrow cultures: recent studies with clonal hematopoietic and stromal cell lines.

Ohta M, Anklesaria P, FitzGerald TJ, Kase K, Leif J, Delamarter J, Farber N, Wright E, Greenberger JS.

Pathol Immunopathol Res. 1989;8(1):1-20. No abstract available.

PMID:
2785687
44.

Recent studies of the hematopoietic microenvironment in long-term bone marrow cultures.

Greenberger JS, FitzGerald TJ, Anklesaria P.

Immunol Res. 1989;8(3):226-35. No abstract available.

PMID:
2664036
45.

Infection of hematopoietic and stromal cells in human continuous bone marrow cultures by a retroviral vector containing the neomycin resistance gene.

Holland CA, Rothstein L, Sakakeeny MA, Anklesaria P, Griffin JD, Harigaya K, Newburger PE, Greenberger JS.

Acta Haematol. 1989;82(3):136-43.

PMID:
2554632
46.

Acute drug interaction between indomethacin and nifedipine in hypertensive patients.

Thatte UM, Shah SJ, Dalvi SS, Suraokar S, Temulkar P, Anklesaria P, Kshirsagar NA.

J Assoc Physicians India. 1988 Dec;36(12):695-8. No abstract available.

PMID:
3235427
47.

Radiosensitivity of cloned permanent murine bone marrow stromal cell lines: nonuniform effect of low dose rate.

FitzGerald TJ, Anklesaria P, Le D, Sakakeeny MA, Kase K, Greenberger JS.

Exp Hematol. 1988 Nov;16(10):820-6.

PMID:
3049129
48.

Bone marrow stromal proteoglycan heterogeneity: phenotypic variability between cell lines and the effects of glucocorticoid.

Bentley SA, Kirby SL, Anklesaria P, Greenberger JS.

J Cell Physiol. 1988 Jul;136(1):182-7.

PMID:
3397395
49.

Plasma rifampicin levels during oral contraception.

Gupta KC, Joshi JV, Anklesaria PS, Shah RS, Satoskar RS.

J Assoc Physicians India. 1988 Jun;36(6):365-6.

PMID:
3182712
50.

Alteration in hematopoietic stem cell seeding and proliferation by both high and low dose rate irradiation of bone marrow stromal cells in vitro.

Greenberger JS, FitzGerald TJ, Klassen V, Anklesaria P, Bushnell D, Kase K, Sakakeeny MA.

Int J Radiat Oncol Biol Phys. 1988 Jan;14(1):85-94.

PMID:
2891657

Supplemental Content

Loading ...
Support Center